Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023421853> ?p ?o ?g. }
- W2023421853 endingPage "2980" @default.
- W2023421853 startingPage "2967" @default.
- W2023421853 abstract "There remains a high unmet medical need for a safe oral therapy for thrombotic disorders. The serine protease factor Xa (fXa), with its central role in the coagulation cascade, is among the more promising targets for anticoagulant therapy and has been the subject of intensive drug discovery efforts. Investigation of a hit from high-throughput screening identified a series of thiophene-substituted anthranilamides as potent nonamidine fXa inhibitors. Lead optimization by incorporation of hydrophilic groups led to the discovery of compounds with picomolar inhibitory potency and micromolar in vitro anticoagulant activity. Based on their high potency, selectivity, oral pharmacokinetics, and efficacy in a rat venous stasis model of thrombosis, compounds ZK 814048 (10b), ZK 810388 (13a), and ZK 813039 (17m) were advanced into development." @default.
- W2023421853 created "2016-06-24" @default.
- W2023421853 creator A5001044333 @default.
- W2023421853 creator A5002605219 @default.
- W2023421853 creator A5002636845 @default.
- W2023421853 creator A5003664206 @default.
- W2023421853 creator A5007068246 @default.
- W2023421853 creator A5017740299 @default.
- W2023421853 creator A5018985536 @default.
- W2023421853 creator A5019399792 @default.
- W2023421853 creator A5029312878 @default.
- W2023421853 creator A5029391182 @default.
- W2023421853 creator A5035224117 @default.
- W2023421853 creator A5041689991 @default.
- W2023421853 creator A5043102095 @default.
- W2023421853 creator A5043444744 @default.
- W2023421853 creator A5046799877 @default.
- W2023421853 creator A5048858417 @default.
- W2023421853 creator A5048952782 @default.
- W2023421853 creator A5050458759 @default.
- W2023421853 creator A5051713813 @default.
- W2023421853 creator A5052166517 @default.
- W2023421853 creator A5060063004 @default.
- W2023421853 creator A5061509643 @default.
- W2023421853 creator A5061989326 @default.
- W2023421853 creator A5063958304 @default.
- W2023421853 creator A5069290672 @default.
- W2023421853 creator A5070605420 @default.
- W2023421853 creator A5075952647 @default.
- W2023421853 creator A5085405772 @default.
- W2023421853 creator A5086201346 @default.
- W2023421853 creator A5089426338 @default.
- W2023421853 creator A5091372096 @default.
- W2023421853 date "2007-05-31" @default.
- W2023421853 modified "2023-10-10" @default.
- W2023421853 title "Thiophene-Anthranilamides as Highly Potent and Orally Available Factor Xa Inhibitors" @default.
- W2023421853 cites W1967089909 @default.
- W2023421853 cites W1967460162 @default.
- W2023421853 cites W1978803630 @default.
- W2023421853 cites W1980601531 @default.
- W2023421853 cites W2005068741 @default.
- W2023421853 cites W2023320697 @default.
- W2023421853 cites W2032901672 @default.
- W2023421853 cites W2038097822 @default.
- W2023421853 cites W2052039776 @default.
- W2023421853 cites W2058310514 @default.
- W2023421853 cites W2058819500 @default.
- W2023421853 cites W2061995169 @default.
- W2023421853 cites W2084651707 @default.
- W2023421853 cites W2103573619 @default.
- W2023421853 cites W2111012458 @default.
- W2023421853 cites W2138787652 @default.
- W2023421853 cites W2160840488 @default.
- W2023421853 cites W2319669995 @default.
- W2023421853 cites W2324450628 @default.
- W2023421853 cites W2418305903 @default.
- W2023421853 cites W2949634541 @default.
- W2023421853 cites W4205279235 @default.
- W2023421853 cites W4256064218 @default.
- W2023421853 doi "https://doi.org/10.1021/jm070125f" @default.
- W2023421853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17536795" @default.
- W2023421853 hasPublicationYear "2007" @default.
- W2023421853 type Work @default.
- W2023421853 sameAs 2023421853 @default.
- W2023421853 citedByCount "41" @default.
- W2023421853 countsByYear W20234218532012 @default.
- W2023421853 countsByYear W20234218532013 @default.
- W2023421853 countsByYear W20234218532014 @default.
- W2023421853 countsByYear W20234218532015 @default.
- W2023421853 countsByYear W20234218532016 @default.
- W2023421853 countsByYear W20234218532017 @default.
- W2023421853 countsByYear W20234218532019 @default.
- W2023421853 countsByYear W20234218532020 @default.
- W2023421853 countsByYear W20234218532021 @default.
- W2023421853 countsByYear W20234218532023 @default.
- W2023421853 crossrefType "journal-article" @default.
- W2023421853 hasAuthorship W2023421853A5001044333 @default.
- W2023421853 hasAuthorship W2023421853A5002605219 @default.
- W2023421853 hasAuthorship W2023421853A5002636845 @default.
- W2023421853 hasAuthorship W2023421853A5003664206 @default.
- W2023421853 hasAuthorship W2023421853A5007068246 @default.
- W2023421853 hasAuthorship W2023421853A5017740299 @default.
- W2023421853 hasAuthorship W2023421853A5018985536 @default.
- W2023421853 hasAuthorship W2023421853A5019399792 @default.
- W2023421853 hasAuthorship W2023421853A5029312878 @default.
- W2023421853 hasAuthorship W2023421853A5029391182 @default.
- W2023421853 hasAuthorship W2023421853A5035224117 @default.
- W2023421853 hasAuthorship W2023421853A5041689991 @default.
- W2023421853 hasAuthorship W2023421853A5043102095 @default.
- W2023421853 hasAuthorship W2023421853A5043444744 @default.
- W2023421853 hasAuthorship W2023421853A5046799877 @default.
- W2023421853 hasAuthorship W2023421853A5048858417 @default.
- W2023421853 hasAuthorship W2023421853A5048952782 @default.
- W2023421853 hasAuthorship W2023421853A5050458759 @default.
- W2023421853 hasAuthorship W2023421853A5051713813 @default.
- W2023421853 hasAuthorship W2023421853A5052166517 @default.
- W2023421853 hasAuthorship W2023421853A5060063004 @default.
- W2023421853 hasAuthorship W2023421853A5061509643 @default.